glp 1 agonist black box warning FDA Says to Drop Suicide From GLP-1 Drug Labels The FDA sent a warning
Description
Long interested in Holst's work, in 1990 Novo Nordisk recruited his colleague Schwartz to develop small molecules able to activate the GLP receptor in the pancreas (Molteni, Chen)
doi: 10.1111/j.1464-5491.2012.03738.x

The Gila monster's bite may be agonising, but humans have been using the lizard's venom to save lives

2 AminianA.ZajichekA.TuC.WolskiK

If no evidence of retinopathy is found and glycemic control is stable, examinations every 1-2 years may be considered

Konig M, Riddle MC, Colhoun HM, et al